Application 203000
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 12.5MG;80MG | No | No |
| 002 | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 12.5MG;160MG | No | No |
| 003 | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 12.5MG;320MG | No | No |
| 004 | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 25MG;160MG | No | No |
| 005 | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 25MG;320MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203000-001 | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;80MG | TABLET / ORAL | 2019-03-15 | ||
| A203000-002 | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;160MG | TABLET / ORAL | 2019-03-15 | ||
| A203000-003 | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;320MG | TABLET / ORAL | 2019-03-15 | ||
| A203000-004 | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 25MG;160MG | TABLET / ORAL | 2019-03-15 | ||
| A203000-005 | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 25MG;320MG | TABLET / ORAL | 2019-03-15 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203000-001 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;80MG | TABLET / ORAL | 2019-03-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A203000-002 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;160MG | TABLET / ORAL | 2019-03-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A203000-003 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;320MG | TABLET / ORAL | 2019-03-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A203000-004 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;160MG | TABLET / ORAL | 2019-03-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A203000-005 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;320MG | TABLET / ORAL | 2019-03-15 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203000-001 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;80MG | TABLET / ORAL | 2019-03-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203000-002 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;160MG | TABLET / ORAL | 2019-03-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203000-003 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;320MG | TABLET / ORAL | 2019-03-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203000-004 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;160MG | TABLET / ORAL | 2019-03-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203000-005 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;320MG | TABLET / ORAL | 2019-03-15 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A203000-001 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;80MG | TABLET / ORAL | 2019-03-15 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A203000-002 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;160MG | TABLET / ORAL | 2019-03-15 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A203000-003 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;320MG | TABLET / ORAL | 2019-03-15 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A203000-004 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;160MG | TABLET / ORAL | 2019-03-15 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A203000-005 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;320MG | TABLET / ORAL | 2019-03-15 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203000-001 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;80MG | TABLET / ORAL | 2019-03-15 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203000-002 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;160MG | TABLET / ORAL | 2019-03-15 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203000-003 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;320MG | TABLET / ORAL | 2019-03-15 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203000-004 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;160MG | TABLET / ORAL | 2019-03-15 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203000-005 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;320MG | TABLET / ORAL | 2019-03-15 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203000-001 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;80MG | TABLET / ORAL | 2019-03-15 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203000-002 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;160MG | TABLET / ORAL | 2019-03-15 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203000-003 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;320MG | TABLET / ORAL | 2019-03-15 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203000-004 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;160MG | TABLET / ORAL | 2019-03-15 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203000-005 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;320MG | TABLET / ORAL | 2019-03-15 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203000-001 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;80MG | TABLET / ORAL | 2019-03-15 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203000-002 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;160MG | TABLET / ORAL | 2019-03-15 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203000-003 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;320MG | TABLET / ORAL | 2019-03-15 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203000-004 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;160MG | TABLET / ORAL | 2019-03-15 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203000-005 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;320MG | TABLET / ORAL | 2019-03-15 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203000-001 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;80MG | TABLET / ORAL | 2019-03-15 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203000-002 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;160MG | TABLET / ORAL | 2019-03-15 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203000-003 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;320MG | TABLET / ORAL | 2019-03-15 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203000-004 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;160MG | TABLET / ORAL | 2019-03-15 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203000-005 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;320MG | TABLET / ORAL | 2019-03-15 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203000-001 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;80MG | TABLET / ORAL | 2019-03-15 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203000-002 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;160MG | TABLET / ORAL | 2019-03-15 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203000-003 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG;320MG | TABLET / ORAL | 2019-03-15 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203000-004 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;160MG | TABLET / ORAL | 2019-03-15 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203000-005 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 25MG;320MG | TABLET / ORAL | 2019-03-15 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | A203000-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A203000-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A203000-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A203000-004 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A203000-005 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| valsartan and hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | bd199010-1d85-4011-939c-4704ecfaba1f | 2022-11-05 | 203000 ANDA203000 70771-1485 70771-1487 70771-1489 70771-1488 70771-1486 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68382-279 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-279 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-280 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-280 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-281 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-281 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-282 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-282 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-283 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-283 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70771-1485 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Cadila Healthcare Limited | ANDA | Current |
| 70771-1485 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Cadila Healthcare Limited | ANDA | Current |
| 70771-1485 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1486 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Cadila Healthcare Limited | ANDA | Current |
| 70771-1486 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Cadila Healthcare Limited | ANDA | Current |
| 70771-1486 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1487 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Cadila Healthcare Limited | ANDA | Current |
| 70771-1487 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Cadila Healthcare Limited | ANDA | Current |
| 70771-1487 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1488 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Cadila Healthcare Limited | ANDA | Current |
| 70771-1488 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Cadila Healthcare Limited | ANDA | Current |
| 70771-1488 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1489 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Cadila Healthcare Limited | ANDA | Current |
| 70771-1489 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Cadila Healthcare Limited | ANDA | Current |
| 70771-1489 | valsartan and hydrochlorothiazide | valsartan and hydrochlorothiazide | Zydus Lifesciences Limited | ANDA | Current |